Market Research Logo

Global Thrombosis Drugs Market 2019-2023

Global Thrombosis Drugs Market 2019-2023

About this market

Sedentary lifestyle is resulting in an increase in the number of thrombosis cases. The increase in sedentary lifestyle is leading to the rise in the prevalence of obesity across the world, thus increasing the risk of thrombosis. Technavio’s analysts have predicted that the thrombosis drugs market will register a CAGR of more than 9% by 2023.

Market Overview

Growing awareness of cardiac care

The increasing awareness of cardiac care is leading to the early diagnosis of various cardiac diseases. Various awareness camps have been organized by the governments and non-government organizations across the world to increase the awareness of heart health among the population.

Strong side-effects of anticoagulants

Anticoagulants or blood thinners are medications that are developed to dissolve blood clots in the body. Blood thinners have high efficacy. However, the side effects associated with the use of these drugs to treat thrombosis are high.

For the detailed list of factors that will drive and challenge the growth of the thrombosis drugs market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be concentrated and with the presence of several companies including Johnson & Johnson, and Sanofi the competitive environment is quite intense. Factors such as the increase in sedentary lifestyle and the increasing awareness of cardiac care, will provide considerable growth opportunities to thrombosis drugs manufactures. Boehringer Ingelheim, Bristol-Myers Squibb, DAIICHI SANKYO, Johnson & Johnson, and Sanofi are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be concentrated and with all companies constantly focusing improving their market positions, the competitive environment among the players is quite intense. The market is witnessing the entry of various generic drug manufacturing companies that are coming up with generic versions of the drugs.’


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global hematology drugs market
      • Table Segments of global hematology drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Pipeline
    • Table Global thrombosis drugs market pipeline: Overview
  • Market segmentation by indication
    • Table Indication - Market share 2018-2023 (%)
    • Comparison by indication
      • Table Comparison by indication
    • Pulmonary embolism - Market size and forecast 2018-2023
      • Table Pulmonary embolism - Market size and forecast 2018-2023 ($ millions)
      • Table Pulmonary embolism - Year-over-year growth 2019-2023 (%)
    • DVT - Market size and forecast 2018-2023
      • Table DVT - Market size and forecast 2018-2023 ($ millions)
      • Table DVT - Year-over-year growth 2019-2023 (%)
    • Market opportunity by indication
      • Table Market opportunity by indication
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Boehringer Ingelheim
      • Table Boehringer Ingelheim - Vendor overview
      • Table Boehringer Ingelheim - Business segments
      • Table Boehringer Ingelheim - Organizational developments
      • Table Boehringer Ingelheim - Geographic focus
      • Table Boehringer Ingelheim - Segment focus
      • Table Boehringer Ingelheim - Key offerings
      • Table Boehringer Ingelheim - Key customers
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb - Vendor overview
      • Table Bristol-Myers Squibb - Business segments
      • Table Bristol-Myers Squibb - Organizational developments
      • Table Bristol-Myers Squibb - Geographic focus
      • Table Bristol-Myers Squibb - Key offerings
      • Table Bristol-Myers Squibb - Key customers
    • DAIICHI SANKYO
      • Table DAIICHI SANKYO - Vendor overview
      • Table DAIICHI SANKYO - Business segments
      • Table DAIICHI SANKYO - Organizational developments
      • Table DAIICHI SANKYO - Geographic focus
      • Table DAIICHI SANKYO - Key offerings
      • Table DAIICHI SANKYO - Key customers
    • Johnson & Johnson
      • Table Johnson & Johnson - Vendor overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson - Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Key customers
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
      • Table Sanofi - Key customers
  • Appendix
    • Research methodology gy
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report